Ares Commercial Real Estate (ACRE)
(Delayed Data from NYSE)
$7.24 USD
+0.23 (3.28%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $7.24 0.00 (0.00%) 5:14 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.24 USD
+0.23 (3.28%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $7.24 0.00 (0.00%) 5:14 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
Zacks News
Ares Commercial Real Estate (ACRE) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Ares Commercial Real Estate (ACRE) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ares Commercial Real Estate (ACRE) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of -163.16% and 2.34%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's What to Expect From HCI Group (HCI) in Q2 Earnings
by Zacks Equity Research
HCI Group's (HCI) second-quarter results are likely to benefit from better performances across its business units.
Is a Beat in Store for Oscar Health (OSCR) in Q2 Earnings?
by Zacks Equity Research
Oscar Health's (OSCR) Q2 results are likely to reflect membership growth, prudent pricing and improved cost-of-care initiatives.
Implied Volatility Surging for Ares Commercial Real Estate (ACRE) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Ares Commercial Real Estate (ACRE) stock based on the movements in the options market lately.
Compared to Estimates, Ares Commercial Real Estate (ACRE) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Ares Commercial Real Estate (ACRE) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ready Capital (RC) Q1 Earnings Top Estimates
by Zacks Equity Research
Ready Capital (RC) delivered earnings and revenue surprises of 3.57% and 24.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Ares Commercial Real Estate (ACRE) Q1 Earnings Expected to Decline
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ares Commercial Real Estate (ACRE) Beats Q4 Earnings Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of 150% and 16.54%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Franklin BSP (FBRT) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Franklin BSP (FBRT) delivered earnings and revenue surprises of -7.14% and 6.95%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Best Income Stocks to Buy January 2nd
by Zacks Equity Research
FFIC, DAN and ACRE made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 2, 2024.
Ares Commercial Real Estate (ACRE) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Ares Commercial Real Estate (ACRE) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ares Commercial Real Estate (ACRE) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of 8.70% and 1.56%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Ready Capital (RC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ready Capital (RC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Ares Commercial Real Estate (ACRE) Q3 Earnings Expected to Decline
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ares Commercial Real Estate (ACRE) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of 9.38% and 3.63%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Ares Commercial Real Estate (ACRE) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of -12.90% and 4.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 27th
by Zacks Equity Research
BCBP, CRMT and ACRE have been added to the Zacks Rank #5 (Strong Sell) List on April 27, 2023.
Implied Volatility Surging for Ares Commercial Real Estate (ACRE) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Ares Commercial Real Estate (ACRE) stock based on the movements in the options market lately.
Ares Commercial Real Estate (ACRE) Q4 Earnings Beat Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of 22.22% and 2.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Apollo Commerical Finance (ARI) Q4 Earnings Lag Estimates
by Zacks Equity Research
Apollo Commerical Finance (ARI) delivered earnings and revenue surprises of -13.89% and 0.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Finance
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Ares Commercial Real Estate (ACRE) Q3 Earnings Top Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of 11.43% and 2.12%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Great Ajax (AJX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Great Ajax (AJX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Ares Commercial Real Estate (ACRE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.